Christoffer Holmberg

Background

About Christoffer Holmberg

From 2023 at Gilead working as Nordic lead for Market Access and Reimbursement across a broad and exciting portfolio of innovative, state-of-the-art medicines for serious illness. From 2011 at BMS working with access, pricing, reimbursement and health economics. Focusing on the Nordic markets, but spent time working with some 10+ different markets in Europe in various roles and/or assignments. From 2007 until 2011 employed at Roche AB focusing mainly on oncology portfolio and health outcomes, health economics, external and governmental affairs, pricing and market access issues. From 2004 until 2007 employed at Schering-Plough Sweden, focusing on health outcomes and public affairs issues. Also involved in different strategic projects / analyses for the Swedish market. Educated in industrial and consumer marketing as well as economics. Worked for two years as a researcher on distribution and marketing of pharmaceuticals at the Stockholm School of Economics Department for Marketing and Strategy. Specialties: Health Outcomes, Managing on-going Health Economics studies, Strategic Pricing, Market Access issues, Public Affairs, Strategic Analyses on market conditions, External Affairs, Governmental Affairs.